From this perspective, based on the increasing application of suPAR as a biomarker for the monitoring of Systemic Chronic Inflammation (SCI) [19], we examined the effects due to uPA/uPAR interaction in the immune cells involved in RA onset and progression. This evidence concerns the gene PLAU and rheumatoid arthritis.